Plain language summary and patient perspective of the ESMO expert consensus statements on treating EGFR-positive NSCLC

Written by Rachel Jenkins; Joanne Walker; Upal Basu Roy

EGFR-positive NSCLC

Future Oncology, our partner journal, has recently published a Plain Language Summary of Publication and patient perspective of the ESMO expert consensus statements on treating EGFR-positive NSCLC. Abstract What is this summary about? This article provides a plain language summary and patient perspective of a new set of recommendations made by the European Society for Medical Oncology (ESMO for short). These recommendations are also called expert consensus statements. They cover the management of people with a type of lung cancer called epidermal growth factor receptor-positive non-small-cell lung cancer (EGFR-positive NSCLC for short). Why were the recommendations developed? The ESMO Clinical...

To view this content, please register now for access

It's completely free